bioRxivBiochemistryPreprint
Mitochondrial Respiratory Chain Function is crucial for Muscle Toxicity in Facioscapulohumeral Muscular Dystrophy
Philipp HeheriD, Jakob Pfeiffer-VogliD, Massimo GanassiiD, Raul-Cristian Fulea, Liam McGuire, Elise N. EngquistiD, M Tyszkiewicz, Johanna PrülleriD, Johannes GrillariiD, Giorgio A. TascaiD, Christopher R. S. BanerjiiD, Peter S. ZammitiD
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is driven by DUX4-induced toxicity, yet the pathomechanisms remain unclear. Here, we identify persistent transcriptional suppression of the mitochondrial respiratory chain and metabolic rewiring in FSHD muscle biopsies and myotubes. Using DUX4-inducible human myogenic cells, we show that DUX4 target gene activation is accompanied by mitochondrial function impairment and Caspase 9-mediated apoptosis. Reverse electron transfer (RET) at complex I is the dominant oxidative stress generating mechanism in FSHD muscle cells. RET-driven mitochondrial reactive oxygen species (mitoROS) are the trigger for oxidative stress and apoptosis, which is a unique feature of FSHD mitochondria. Pharmacological inhibition of RET suppresses mitoROS, reduces Caspase 9 activation, and rescues abnormal myogenesis in FSHD cell lines. Importantly, DUX4 is non-toxic in oxidative phosphorylation-deficient human myogenic cells. Our findings identify the mitochondrial respiratory chain as a key mediator of DUX4 toxicity and highlight RET inhibition as a potential therapeutic approach for FSHD. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=136 SRC="FIGDIR/small/690559v1_ufig1.gif" ALT="Figure 1"> View larger version (48K): org.highwire.dtl.DTLVardef@254927org.highwire.dtl.DTLVardef@1e5c67forg.highwire.dtl.DTLVardef@4ace42org.highwire.dtl.DTLVardef@12b710e_HPS_FORMAT_FIGEXP M_FIG (Created with BioRender.com) C_FIG
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Interplay between mitochondria and reactive oxygen and nitrogen species in metabolic adaptation to hypoxia in facioscapulohumeral muscular dystrophy: potential therapeutic targets.
P. Heher, M. Ganassi, … P. S. Zammit·bioRxiv·Sep 8, 2021
- Metformin enhances differentiation and function of skeletal muscle in models of Facioscapulohumeral Muscular Dystrophy (FSHD)
Joshua Greig, Jiani Qian, … Peter S. Zammit·bioRxiv·Jul 31, 2026
- Quantifying anti-DUX4 therapy for facioscapulohumeral muscular dystrophy
Matthew V. Cowley, Peter S. Zammit, Christopher R. S. Banerji·bioRxiv·Aug 14, 2024
- Posttranslational modifications of the DUX4 protein impact toxic function
Renatta N. Knox, Jocelyn O. Eidahl, … Scott Q. Harper·bioRxiv·Jul 22, 2022
- LEUTX mediates amplification of DUX4 signaling and aberrant myotube differentiation in facioscapulohumeral muscular dystrophy
Xiangduk Kong, Sung Jun Beck, … Kyoko Yokomori·bioRxiv·Oct 29, 2026
- Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy
Amelia Fox, Jonathan Oliva, … Francis M. Sverdrup·bioRxiv·May 21, 2024